Takayuki Imoto

This inventor holds 11 USPTO granted patents and 14 published patent applications and 11 EPO patents. Top assignees: Nissan Chemical Industries Limited, Kyushu University. Active years: 2015-2023.

USPTO Granted Patents = 11 (Patent Applications = 14)

% Patents Active = 81.8

EPO Patents = 11 (Patent Applications = 21)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

11 out of 1,235

Nissan Chemical Industries Limited

where one patent can have more than one assignee

Years Active: 2015-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11771645 - Transdermally absorbable base material containing lipid peptide compound (2023-10-03),

2. 11452688 - Transdermally absorbable base material containing lipid peptide compound (2022-09-27),

3. 10421055 - Dispersion and method for forming hydrogel (2019-09-24),

4. 10105294 - Dispersion and method for forming hydrogel (2018-10-23),

5. 10092496 - Stick-shaped base material containing lipid peptide compound (2018-10-09),

6. 10071044 - Thickened composition containing lipid peptide-type compound (2018-09-11),

7. 9782331 - Dispersion and method for forming hydrogel (2017-10-10),

8. 9566218 - Production method of cosmetic, preparation method of gel for cosmetics, and method of reducing use amount of polymer thickener blended in cosmetic raw materials (2017-02-14),

9. 9561255 - Cosmetic, external skin preparation, and medical instrument (2017-02-07),

10. 9480772 - Gel sheet containing lipid peptide gelator and polymeric compound (2016-11-01),

11. 8999300 - Cosmetic, external skin preparation, and medical instrument (2015-04-07),

Title: Takayuki Imoto: Innovator in Transdermal Technology

Introduction

Takayuki Imoto is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the field of transdermal technology, holding a total of 11 patents. His work focuses on developing innovative materials that enhance the delivery of therapeutic compounds through the skin.

Latest Patents

One of his latest patents is a transdermally absorbable base material containing a lipid peptide compound. This invention includes a lipid peptide compound, a surfactant, a specific polyhydric alcohol, a fatty acid, and water. The formulation is designed to improve the absorption of therapeutic agents through the skin, making it a valuable advancement in transdermal drug delivery systems.

Career Highlights

Throughout his career, Takayuki Imoto has worked with notable organizations such as Nissan Chemical Industries Limited and Kyushu University. His experience in these institutions has allowed him to refine his expertise in material science and drug delivery technologies.

Collaborations

He has collaborated with esteemed colleagues, including Takehisa Iwama and Nobuhide Miyachi. These partnerships have contributed to the development of innovative solutions in the field of transdermal applications.

Conclusion

Takayuki Imoto's contributions to transdermal technology highlight his role as a leading inventor in this specialized field. His innovative patents and collaborations continue to influence advancements in drug delivery systems.